Stock Information
ACADIA Pharmaceuticals Inc (ACAD)
Ticker Symbol: ACAD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,653.70 mil
Piotroski score: 4
PE Ratio: 11.5282
EPS (TTM): 2.1884
Revenue (TTM): $6.34 M
Dividend Yield: N/A%
ROE: 35.65%
Latest News
-
B of A Securities Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $30
Tue, Jun 30, 2026 1:36 PM
-
Taysha: 'Buy' On Interim Analysis Of TSHA-102 First Half 2027 And Broad Label Potential
Tue, Jun 30, 2026 9:38 AM
-
Acadia Pharmaceuticals: Steady Commercial Progress, Remlifanserin Data In Focus
Mon, Jun 29, 2026 11:19 AM
-
Citigroup Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $35
Mon, Jun 29, 2026 10:02 AM
-
Canaccord Genuity Maintains Buy on ACADIA Pharmaceuticals, Raises Price Target to $36
Mon, Jun 29, 2026 9:36 AM
-
Traders are paying attention to the gapping stocks in Friday's session.
Fri, Jun 26, 2026 2:30 PM
-
Acadia Pharma Stock Jumps After European Panel Reverses Course On Rett Syndrome Therapy
Fri, Jun 26, 2026 1:47 PM
-
Crude Oil Falls 4%; US Consumer Sentiment Rises In June
Fri, Jun 26, 2026 12:17 PM
-
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
Fri, Jun 26, 2026 10:18 AM
-
12 Health Care Stocks Moving In Friday's Pre-Market Session
Fri, Jun 26, 2026 8:05 AM
Key Financials
Financial data not available
